ADAMTS-13 activity reduction in plasma of acute myeloid leukemia predicts poor prognosis after bone marrow transplantation.
CONCLUSION: AML patients with low activity of ADAMTS-13 had worse prognosis after BMT.
PMID: 30322352 [PubMed - as supplied by publisher]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Bone Marrow Transplant | Hematology | Laboratory Medicine | Leukemia | Lung Transplant | Transplants